Quantcast
Last updated on April 24, 2014 at 10:47 EDT

Latest Guillain-Barre syndrome Stories

2012-06-26 18:20:39

ROTTERDAM, Netherlands, June 27, 2012 /PRNewswire/ -- Data presented today from the Privigen Impact on Mobility and Autonomy (PRIMA) trial at the Peripheral Nerve Society Inflammatory Neuropathy Consortium Meeting in Rotterdam, Netherlands, suggests that treatment with Privigen® [Immune Globulin Intravenous (Human), 10% Liquid], an intravenous immunoglobulin (IVIg), may lead to improvement in function in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). PRIMA, a...

2012-05-07 02:32:55

Complement Pathway Modulation at Center of Collaboration CAMBRIDGE, Mass. and AMSTERDAM, May 7, 2012 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that it has entered into a partnership with Regenesance to investigate a potential treatment for ALS (aka Motor Neurone or Lou Gehrig's disease). The collaboration will enable ALS TDI, the world's largest ALS drug development center, to screen novel compounds against a crucial pathway implicated in...

2012-03-27 11:54:22

Intravenous immune globulin (IVIg) is an effective treatment for certain disorders of the nerve and muscles, including Guillain-Barré syndrome (GBS) and a form of neuropathy called chronic inflammatory demyelinating polyneuropathy (CIDP), according to a guideline issued by the American Academy of Neurology. The guideline is published in the March 27, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology. IVIg is a type of immunotherapy...

2011-03-03 00:00:29

The deVere Group, the world's largest independent financial consultancy group has raised £72,030 in funds towards Combat Stress, Guillain-Barre syndrome support group, as well as Inspire, from world-wide sponsors including deVere partners and deVere staff. (PRWEB) March 02, 2011 The deVere Group, the world's largest independent financial consultancy group has raised £72,030 in funds towards Combat Stress, Guillain-Barre syndrome support group, as well as Inspire, from...

2010-11-05 06:16:00

MADISON, Wis., Nov. 5, 2010 /PRNewswire/ -- Armed with the latest information, physicians can diagnose patients with Guillain-Barre Syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP) more easily and earlier, increasing the chances of successful recovery. Thanks to a partnership between Sonic Foundry, Inc. (Nasdaq: SOFO), the recognized market leader for rich media webcasting and knowledge management, and the GBS/CIDP Foundation International, the most recent...

2010-10-29 07:00:00

KING OF PRUSSIA, Pa., Oct. 29 /PRNewswire/ -- To demonstrate its continued commitment to innovative immunoglobulin (Ig) research, CSL Behring announced today it has created the Interlaken Leadership Awards. This global awards program will provide monetary grants to advance medical research and knowledge about the potential role of immunoglobulin therapy in the treatment of neurologic disorders. From the management of primary immunodeficiency to the control of autoimmune and inflammatory...

2010-09-15 14:25:00

NARBERTH, Pa., Sept. 15 /PRNewswire/ -- The GBS/CIDP Foundation International will host its eleventh international symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in King of Prussia, PA, November 5-7, 2010. Over 400 medical professionals, current and former patients, and caregivers from all over the world are expected to attend the three-day event at the Dolce Hotel - Valley Forge. In addition to general sessions covering the latest...

2010-06-23 11:06:00

NARBERTH, Pa., June 23 /PRNewswire/ -- The GBS/CIDP Foundation International today announced the designation of seven initial "Centers of Excellence" for the diagnosis and treatment of Guillain-Barre syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and variants. The centers will form a network of healthcare facilities to provide expert diagnosis and management of inflammatory neuropathies for patients who are unable to consult with medical experts in the field in...

2009-06-17 13:56:00

NARBERTH, Pa., June 17 /PRNewswire/ -- The GBS/CIDP Foundation International, the only non-profit organization dedicated to serving patients afflicted with Guillain-Barre Syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and variants, announced the appointment of Patricia A. Bryant to the position of Executive Director effective as of May 2009. Patricia succeeds Estelle L. Benson, who along with her husband, Robert Benson, founded the volunteer organization in 1980...

2009-06-10 10:56:57

 New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed. Eduardo De Sousa, M.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and director of the Electrodiagnostic Neuromuscular Lab at JHN, led the study which looked at the number of demyelinating features that are needed to differentiate between CIDP, Amyotrophic lateral sclerosis (ALS, or Lou...